KemPharm Stock News

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, March 30, 2022, 5:00 p.m. ET

Data demonstrate higher doses of SDX were generally well-tolerated and produced targeted pharmacodynamic effects that may be beneficial for the treatment of idiopathic hypersomnia (IH) and other sleep

KemPharm (KMPH), a maker of prodrugs, announced on Wednesday that the company would receive a $1.975 million fee from Corium Inc. following the U.S

KemPharm team provided development and regulatory services to Corium pursuant to a master development services agreement

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, March 30, 2022, 5:00 p.m. ET

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, March 30, 2022, 5:00 p.m. ET

KemPharm Positioned to Submit IND Application for KP1077 for Idiopathic Hypersomnia by Mid-2022

Upgrades UBS upgraded the previous rating for Align Technology Inc (NASDAQ:ALGN) from Neutral to Buy. For the third quarter, Align Tech had an EPS of $2.87, compared to year-ago quarter EPS of $2.25.

Futures Recover From Wednesday Rout As Yields, VIX Stabilize Whereas the stock plunge on Tuesday could be blamed on surging rates, the repeat tumble on Wednesday took place as Treasury yields dropped sharply, so with markets at a loss how to read rate signals, so far this morning S&P e-mini futures have rebounded by 23 points ot 0.5% from yesterday''s low just above 4,500 - a key support level according to JPMorgan - as volatility eased and global bond yields appear to have stabilize for now, and hours after China''s latest easing measure when Beijing lowered mortgage lending benchmark rates on Thursday as monetary authorities step up efforts to prop up the slowing economy. 10Y Treasuries rose from session lows, last trading at 1.84%, European stocks fluctuated as the dollar index was little changed and crude oil slipped after a three-day rally as gold held around a two-month high. China''s cut to the one-year and five-year loan prime rates (LPR) which lowered the one-year LPR by 10 basis points to 3.70% from 3.80% - the second consecutive monthly cut - and the five-year LPR by 5 basis points to 4.60% from 4.65%, its first cut since April 2020. ... followed surprise cuts by China''s central bank on Monday to its short- and medium-term lending rates, and came days after the central bank''s vice governor flagged more moves ahead.

KemPharm Inc (NASDAQ: KMPH) has selected KP1077 for idiopathic hypersomnia (IH) as its lead serdexmethylphenidate (SDX) candidate in the pipeline. Idiopathic hypersomnia is an uncommon sleep disorder

KemPharm (KMPH) has added ~3.9% in the post-market after announcing the selection of KP1077 for idiopathic hypersomnia ((IH)) as its lead serdexmethylphenidate ((SDX)) candidate in

KemPharm to Advance KP1077 for Idiopathic Hypersomnia as Lead SDX Product Candidate

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, January 19, 2022 at 4:30 p.m. ET

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, January 19, 2022 at 4:30 p.m. ET

Data highlight key pharmacokinetic properties of serdexmethylphenidate that are instrumental to its consistent and smooth release of d-MPH